Metformin trials for Type 2 diabetes

All Metformin trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying Metformin for Type 2 diabetes

• A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes
  NCT06972732 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
  NCT05469659 · Phase: Phase 2 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
  NCT07093476 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study
  NCT06888050 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
  NCT04670666 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control
  NCT07244003 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Glycemic Variability of Combination Therapies in T2DM
  NCT07442006 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Impact of P53 and SIRT1 in Type 2 Diabetes
  NCT03925714 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)
  NCT02969798 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Precision Dosing of Metformin in Youth With T2D
  NCT06120881 · Phase: Early Phase 1 · Ages: 10 Years to 21 Years · Sex: All (male and female) · 2 locations
• SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
  NCT05345327 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• The EMPA-FIT Study
  NCT06846411 · Phase: Phase 4 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• The Effect of Empagliflozin and Metformin on Oxidative Capacity and Microvascular Reactivity of Skeletal Muscle in Patients With Type 2 Diabetes Mellitus
  NCT07771010 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: Male · 1 location

Common questions

How many trials study Metformin for Type 2 diabetes?

13 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.